17265-59-7Relevant academic research and scientific papers
HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR
-
Paragraph 0179; 0182-0183, (2020/01/22)
10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives of formula (I) as hepatitis B surface antigen inhibitors or pharmaceutically acceptable salts thereof, and uses of a compound of formula (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof in preparation of medicaments for treatment of viral hepatitis B.
